Trial registration Keywords: Metabolic syndrome, Very-low-calorie-diet, L-carnitine, Weight loss Introduction Metabolic syndrome (MetS) is defined as a cluster of cardiovascular risk factors (i.e., abdominal obesity, hyperinsulinaemia, atherogenic dyslipidemia, hypertension, hypercogauability) that increase the risk of developing co-existing coronary heart disease (CHD) and type 2 diabetes [1]
Additionally, empagliflozin has exhibited inhibitory effects on diverse tumor types, including pancreatic and prostate cancers [32]
After several years of research on biological therapies and small molecules to target inflammation, we need a different strategy to further get more insights into mechanisms underlying rheumatoid arthritis pathogenesis and identify potential new treatments, as a significant proportion of patients are partial responders
Autophagy maintains the metabolism and function of young and old stem cells